A comparative ethical analysis of the Egyptian clinical research law

IF 3 1区 哲学 Q1 ETHICS BMC Medical Ethics Pub Date : 2024-04-30 DOI:10.1186/s12910-024-01040-0
Sylvia Martin, Mirko Ancillotti, Santa Slokenberga, Amal Matar
{"title":"A comparative ethical analysis of the Egyptian clinical research law","authors":"Sylvia Martin, Mirko Ancillotti, Santa Slokenberga, Amal Matar","doi":"10.1186/s12910-024-01040-0","DOIUrl":null,"url":null,"abstract":"In this study, we examined the ethical implications of Egypt’s new clinical trial law, employing the ethical framework proposed by Emanuel et al. and comparing it to various national and supranational laws. This analysis is crucial as Egypt, considered a high-growth pharmaceutical market, has become an attractive location for clinical trials, offering insights into the ethical implementation of bioethical regulations in a large population country with a robust healthcare infrastructure and predominantly treatment-naïve patients. We conducted a comparative analysis of Egyptian law with regulations from Sweden and France, including the EU Clinical Trials Regulation, considering ethical human subject research criteria, and used a directed approach to qualitative content analysis to examine the laws and regulations. This study involved extensive peer scrutiny, frequent debriefing sessions, and collaboration with legal experts with relevant international legal expertise to ensure rigorous analysis and interpretation of the laws. On the rating of the seven different principles (social and scientific values, scientific validity, fair selection of participants, risk-benefit ratio, independent review, informed consent and respect for participants) Egypt, France, and EU regulations had comparable scores. Specific principles (Social Value, Scientific Value, and Fair selection of participants) were challenging to directly identify due to certain regulations embodying 'implicit' principles more than explicitly stated ones. The analysis underscores Egypt's alignment with internationally recognized ethical principles, as outlined by Emanuel et al., through its comparison with French, Swedish, and EU regulations, emphasizing the critical need for Egypt to continuously refine its ethical regulations to safeguard participant protection and research integrity. Key issues identified include the necessity to clarify and standardize the concept of social value in research, alongside concerns regarding the expertise and impartiality of ethical review boards, pointing towards a broader agenda for enhancing research ethics in Egypt and beyond.","PeriodicalId":55348,"journal":{"name":"BMC Medical Ethics","volume":"106 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Ethics","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1186/s12910-024-01040-0","RegionNum":1,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we examined the ethical implications of Egypt’s new clinical trial law, employing the ethical framework proposed by Emanuel et al. and comparing it to various national and supranational laws. This analysis is crucial as Egypt, considered a high-growth pharmaceutical market, has become an attractive location for clinical trials, offering insights into the ethical implementation of bioethical regulations in a large population country with a robust healthcare infrastructure and predominantly treatment-naïve patients. We conducted a comparative analysis of Egyptian law with regulations from Sweden and France, including the EU Clinical Trials Regulation, considering ethical human subject research criteria, and used a directed approach to qualitative content analysis to examine the laws and regulations. This study involved extensive peer scrutiny, frequent debriefing sessions, and collaboration with legal experts with relevant international legal expertise to ensure rigorous analysis and interpretation of the laws. On the rating of the seven different principles (social and scientific values, scientific validity, fair selection of participants, risk-benefit ratio, independent review, informed consent and respect for participants) Egypt, France, and EU regulations had comparable scores. Specific principles (Social Value, Scientific Value, and Fair selection of participants) were challenging to directly identify due to certain regulations embodying 'implicit' principles more than explicitly stated ones. The analysis underscores Egypt's alignment with internationally recognized ethical principles, as outlined by Emanuel et al., through its comparison with French, Swedish, and EU regulations, emphasizing the critical need for Egypt to continuously refine its ethical regulations to safeguard participant protection and research integrity. Key issues identified include the necessity to clarify and standardize the concept of social value in research, alongside concerns regarding the expertise and impartiality of ethical review boards, pointing towards a broader agenda for enhancing research ethics in Egypt and beyond.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃及临床研究法的伦理比较分析
在本研究中,我们采用伊曼纽尔等人提出的伦理框架,并将其与各种国家和超国家法律进行比较,研究了埃及新临床试验法的伦理影响。这一分析至关重要,因为埃及被认为是一个高增长的医药市场,已成为一个具有吸引力的临床试验地点,为在一个人口众多、医疗基础设施健全、以治疗无效患者为主的国家实施生物伦理法规提供了启示。我们将埃及的法律与瑞典和法国的法规(包括欧盟临床试验法规)进行了比较分析,考虑到了人类受试者研究的伦理标准,并采用了定性内容分析的定向方法来研究法律法规。这项研究涉及广泛的同行审查、频繁的汇报会以及与具有相关国际法律专业知识的法律专家的合作,以确保对法律进行严格的分析和解释。在七项不同原则(社会和科学价值、科学有效性、公平选择参与者、风险收益比、独立审查、知情同意和尊重参与者)的评分方面,埃及、法国和欧盟的法规得分相当。具体原则(社会价值、科学价值和公平选择参与者)很难直接确定,因为某些法规更多体现的是 "隐含 "原则,而不是明文规定的原则。这项分析通过与法国、瑞典和欧盟的法规进行比较,强调了埃及与伊曼纽尔等人概述的国际公认伦理原则的一致性,同时强调埃及亟需不断完善其伦理法规,以保障参与者的保护和研究的完整性。所发现的关键问题包括有必要澄清研究中的社会价值概念并使之标准化,以及对伦理审查委员会的专业知识和公正性的担忧,这些都为加强埃及及其他国家的研究伦理提出了更广泛的议程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Medical Ethics
BMC Medical Ethics MEDICAL ETHICS-
CiteScore
5.20
自引率
7.40%
发文量
108
审稿时长
>12 weeks
期刊介绍: BMC Medical Ethics is an open access journal publishing original peer-reviewed research articles in relation to the ethical aspects of biomedical research and clinical practice, including professional choices and conduct, medical technologies, healthcare systems and health policies.
期刊最新文献
A case study of Muslims' perspectives of expanded terminal sedation:addressing the elephant in the room. Ethical issues in vaccine trial participation by adolescents: qualitative insights on family decision making from a human papillomavirus vaccine trial in Tanzania. Scoping review and thematic analysis of informed consent in humanitarian emergencies. Healthcare workers' opinions on non-medical criteria for prioritisation of access to care during the pandemic. "I think all of us should have […] much better training in ethics." Ethical challenges in policy making during the COVID-19 pandemic: Results from an interview study with Swiss policy makers and scientists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1